Registry Data Show Vedolizumab, Ustekinumab Safe in Pregnancy

Sunanda Kane, MD, on Moderate, Severe, and Refractory Crohn's Disease

Management of inflammatory bowel disease beyond tumor necrosis factor inhibitors: novel biologics and small-molecule drugs

WJMH :: World Journal of Men's Health

Ustekinumab in Dermatology: Approved Indications and Off-label Uses

Vedolizumab: Uses, Interactions, Mechanism of Action

About IBD Podcast Episode 92 - IBD and Pregnancy With Jill Gaidos, MD

Evidence-based clinical practice guidelines for inflammatory bowel disease 2020

Clinical evaluation of risankizumab for Crohn's disease

Ustekinumab is associated with superior treatment persistence but not with higher remission rates versus vedolizumab in patients with refractory Crohn's disease: results from a multicentre cohort study - Péter Bacsur, Mária Matuz

Inflammatory bowel disease in pregnancy and breastfeeding

Next generation of biologics for the treatment of Crohn's disease: an evidence-based review on ustekinumab. - Abstract - Europe PMC

Pregnancy by francis berenbaum - Issuu

PDF) Differences in the placental pharmacokinetics of vedolizumab and ustekinumab during pregnancy in women with inflammatory bowel disease: a prospective multicentre study

Ustekinumab

Crohn's disease and clinical management today: How it does?